Rep. Michael Guest

Maddy summaryHRES 803 is a non-binding resolution urging the FDA to reassess the safety of all chemical abortion drugs based on recent independent studies. It specifically requests the FDA reevaluate safety data and publicly release a full safety review including real-world complications. The resolution does not change laws or create new requirements but asks the FDA to consider findings that claim complication rates are 22 times higher than current reports. This resolution directly addresses the FDA's regulatory oversight of these drugs, not other entities or policies.

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).

Maddy summaryThis bill requires the FDA to reinstate the 2011 safety program for mifepristone (the drug sold as Mifeprex) and bans its importation into the U.S. It creates federal liability for harm caused by illegal importers of the drug, allowing lawsuits for bodily injury or mental health harm resulting from unauthorized importation. The law applies specifically to telehealth providers, pharmacies, or others who knowingly import mifepristone across state lines. It takes effect 90 days after enactment.

Maddy summaryHR 5573, the Combatting Fentanyl Poisonings Act of 2025, creates three federal grant programs to address fentanyl-related harms. It funds state/local law enforcement to target illegal social media sales of controlled substances (including fentanyl-laced counterfeit pills) and provides education for schools and parents about fentanyl risks. Nonprofits receive grants up to $50,000 to run public awareness campaigns, produce educational materials, and offer counseling for families affected by fentanyl deaths - though funds cannot cover most harm reduction supplies (only naloxone is permitted). The bill allocates $10 million for law enforcement programs, $3 million for awareness grants, and $2 million for officer safety equipment like fentanyl test strips and naloxone training.

Maddy summaryHR 5596, the FARMS Act, freezes the current wage rate for H-2B visa workers for two years after enactment. It directly affects H-2B nonimmigrant workers and their employers by preventing increases to the required wage rate during this period. The bill allows the Secretary of Labor to retain the existing wage rate if they determine a valid calculation method for the new rate is unavailable. This provides temporary stability to employers hiring H-2B workers without requiring immediate changes to wage payments.

Maddy summaryHRES 719 is a House resolution honoring Charles "Charlie" James Kirk, the founder of Turning Point USA who was assassinated on September 10, 2025. The resolution condemns his assassination and all political violence, extends condolences to his family, and calls on Americans to reject violence while promoting civil discourse. It specifically recognizes Kirk's legacy as a defender of constitutional principles and his role in inspiring youth through free speech and faith-based civic engagement. As a commemorative resolution, it does not enact policy changes but formally expresses the House's stance on honoring his life and legacy.

Maddy summaryThis bill requires health plans and insurers to create a clear, timely process for patients or doctors to request exceptions when step therapy protocols (which force patients to try cheaper drugs first) might harm them. It mandates approval for exceptions in six specific cases, such as when prior treatments failed, delaying care risks severe harm, or the required drug causes adverse reactions. Plans must respond within 72 hours (24 hours for emergencies) and cover the requested drug for at least one year if approved. Additionally, health plans must report annual data on exception requests, approvals, denials, and reasons to the government for transparency.

Maddy summaryThis federal bill requires abortion providers to inform patients about potential reversal of mifepristone-based chemical abortions (the two-drug process) at least 24 hours before the procedure. After the first drug is dispensed, providers must give written instructions stating that reversal may be possible if the second pill hasn't been taken. Facilities must post visible signs about reversal options, and the government must maintain a website with reversal resources. Violations allow affected patients or family members to sue for damages.

Maddy summaryHR 5483, the Chloe Cole Act, prohibits health care professionals, hospitals, or clinics from providing certain gender-affirming treatments to minors under 18 that aim to alter their body to align with a gender identity different from their sex assigned at birth. This includes puberty blockers, sex hormones, and specific surgeries, unless the treatment falls under narrow exceptions like medically necessary care for disorders of sexual development, injuries, or detransition. The bill creates a private right for affected minors or their guardians to sue providers for damages in federal court, with strict liability for violations. It applies when interstate commerce is involved (e.g., payments, travel, communications) and sets a 25-year statute of limitations from the minor’s 18th birthday.